Kry, the Swedish telehealth company also known as Livi in the UK and France, has raised US$160m of debt and equity funding in Series D follow-on funding. However, the firm has kept a tight lid on its valuation and observers are conflicted as to why this is.
Archives
Centene sells Ribera
US healthcare giant Centene confirmed it has sold its Spanish and Central European subsidiaries to French private hospital group Vivalto Santé, but has yet to find a buyer for Circle Health, the second largest UK hospital chain.
July 29, 2022
HBI 2022: Everyone sees the benefits of sharing data, but not everyone is willing to share
In a recent survey, 90% of surveyed patients agreed that everyone can benefit from the sharing of patient data – but 23% said they would be reluctant to share their own data - even if it was private. Dr Nick West, chief medical officer, global medical affairs, Abbott Vascular, explained more about the benefit of sharing data at HBI 2022.
July 22, 2022
Private Chinese hospitals in good health
Consulting group L.E.K. has released the results of its analysis Hospital Priorities 2022 (China edition). The survey of 120 hospital executives explains the sector’s focus points and achievements thus far and the implications of these priorities for pharma and medtech firms.
July 22, 2022
FREE BLOG Blog: Who has the worst waiting lists?
NHS England's staggering 6.6m waiting list almost certainly had led to a 39% rise to 69,000 in patients paying to go private in the fourth quarter of 2021. What’s worse – only about two thirds of it is thanks to the pandemic. Ireland has an even worse per capita waiting list but what about other European countries?
July 22, 2022
Infographic: UK and Ireland have the worst waiting lists
England’s staggering waiting list for elective care, which sits at 6.6 million people at time of writing, is unsurprisingly much worse than most other NHS-style systems and very close to the levels in Ireland. Eagle-eyed readers may have already noticed the lack of Bismarckian systems – a triumph of mandatory-insurers? Not necessarily.
July 22, 2022
Bid may undervalue Mediclinic
South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.
July 20, 2022
Four Seasons announces sale of bulk of care homes
UK-based elderly care providers Four Seasons Healthcare Group is for sale, again, this time putting 111 of its 130 care homes up for sale in two weeks time.
July 15, 2022
Ramsay may sell French subsidiary to ease the path for KKR takeover
The Australia-based multinational hospital group Ramsay may sell its share in French subsidiary Ramsay Santé so private equity firm KKR’s proposed AU$88 per share takeover of the group doesn't come under fire from France’s competition authority – but this raises issues with the deal.
July 14, 2022
HBI 2022: Building digital health ecosystems
Covid-19 forced the increased adoption of technology to aid healthcare delivery. The HBI 2022 digital ecosystem panel said in some ways this was detrimental – digital without physical doesn’t lead to quality patient outcomes – but a robust digital health ecosystem must be a priority for the sector moving forward.
July 14, 2022
Providers criticise Lancet study on correlation between NHS outsourcing and excess deaths
A new study published in the Lancet showing a correlation between increased outsourcing by the UK's NHS to for-profit providers with increased treatable deaths has been rubbished by several in the independent healthcare industry.
July 14, 2022
HBI 2022: Integrated care is tricky – but worth it
Integrated care is well worth delivering. Not only can it help to break down the silos which get in the way of efficient healthcare delivery, but some very effective tools can only be used with integration. A panel at HBI 2022 asked: What do firms have to consider before they can deliver it?
